Question 1

What is T-cell lymphoma?

Accepted Answer

T-cell lymphoma is a group of cancers that develop from T-cells, a type of white blood cell in your immune system. T-cell lymphomas are relatively rare, accounting for about 10-15% of all non-Hodgkin lymphomas.

Question 2

How do I know which subtype I have?

Accepted Answer

Your subtype is determined by your pathology report — the analysis of tissue from your biopsy. It's usually listed in the final diagnosis section of your pathology report.

Question 3

What is PTCL-NOS?

Accepted Answer

PTCL-NOS stands for Peripheral T-Cell Lymphoma, Not Otherwise Specified. It's the most common PTCL subtype, accounting for about 25-30% of all peripheral T-cell lymphoma cases.

Question 4

What is the difference between PTCL and CTCL?

Accepted Answer

PTCL (Peripheral T-Cell Lymphoma) and CTCL (Cutaneous T-Cell Lymphoma) are both T-cell lymphomas, but they behave differently. PTCL affects lymph nodes and organs; CTCL primarily affects the skin.

Question 5

What does ALK-positive or ALK-negative mean in ALCL?

Accepted Answer

ALCL (Anaplastic Large Cell Lymphoma) is divided into ALK-positive and ALK-negative types based on whether the cells produce the ALK protein.

Question 6

What is AITL / T-follicular helper lymphoma?

Accepted Answer

AITL (Angioimmunoblastic T-Cell Lymphoma) is now also classified under the broader category of T-follicular helper (TFH) lymphomas. It accounts for about 15-20% of PTCL cases.

Question 7

What are mycosis fungoides and Sézary syndrome?

Accepted Answer

Mycosis fungoides (MF) and Sézary syndrome are the two most common forms of cutaneous T-cell lymphoma (CTCL).

Question 8

What is a clinical trial?

Accepted Answer

A clinical trial is a carefully designed research study that tests new treatments, drugs, or approaches in patients. Every cancer treatment used today was once tested in a clinical trial.

Question 9

Are clinical trials safe?

Accepted Answer

Clinical trials are carefully regulated to protect participants, with IRB oversight, informed consent, ongoing monitoring, and the right to withdraw at any time.

Question 10

What do Phase 1, Phase 2, and Phase 3 mean?

Accepted Answer

Clinical trials proceed through phases. Phase 1 tests safety and dosing, Phase 2 tests effectiveness, and Phase 3 compares a new treatment to the current standard.

Question 11

Will I receive a placebo (sugar pill)?

Accepted Answer

In cancer trials, pure placebo-only arms are extremely rare. Most cancer trials use placebos only in addition to standard treatment, and many T-cell lymphoma trials don't use placebos at all.

Question 12

Will I have to pay for a clinical trial?

Accepted Answer

In most clinical trials, the investigational drug and study-related tests are free. You may still be responsible for standard-of-care costs and travel expenses.

Question 13

How do I bring up clinical trials with my oncologist?

Accepted Answer

It's completely appropriate to ask your oncologist about clinical trials. You can use our Letter Generator to create a personalized letter to bring to your appointment.

Question 14

How does TrialCompass find and curate trials?

Accepted Answer

Every trial in our database is individually reviewed by a hematology/oncology specialist who classifies subtype, treatment stage, priority, and writes a plain language summary.

Question 15

Is TrialCompass really free?

Accepted Answer

Yes. TrialCompass is 100% free and always will be. No paywalls, no premium tiers, no hidden costs.

Question 16

Does TrialCompass replace my oncologist's advice?

Accepted Answer

No. TrialCompass is an informational tool — it does not provide medical advice. Always discuss any clinical trial you're interested in with your oncologist or healthcare team.

Understanding T-Cell Lymphoma & Clinical Trials

Understanding Your Diagnosis

About Clinical Trials

Using TrialCompass

Still have questions?

Ask our AI Assistant

Browse Resources

Contact Us